Overview
Choosing an ERP for a pharmaceutical group is never a simple product comparison. The decision affects how companies manage product data, inventory, manufacturing, finance, commercial operations, quality controls and regional growth. It also sets the level of change the organization can sustain for years.
The upcoming Odoo Experience 2026 session, “Choosing Odoo Over SAP: The 10-Year Transformation Journey of a Global Pharmaceutical Group”, offers a useful case context. Amit Parik of BrowseInfo will discuss Sasmar’s long Odoo journey, including expansion from a small number of entities to 22 companies and the operational challenges of manufacturing, inventory and accounting at global scale.
One clarification matters: Sasmar evaluated SAP but chose Odoo. This was not a migration from SAP to Odoo. The value of the story is not that one platform wins by default. It is the questions that a 10-year decision raises for any global pharmaceutical ERP evaluation.
This article presents those questions as a decision framework. For the detailed customer story, visit the Sasmar pharma case study.
The Real Decision Is an Operating Model Decision
“Should we choose Odoo or SAP?” is too broad. A better question is: which ERP operating model can support the required controls, standardization, local needs, growth and rate of change?
ERP selection should begin with the work that must be governed. A pharma group may need product and batch traceability, controlled commercial terms, manufacturing planning, stock accuracy, intercompany flows, multi-currency finance, eCommerce connections and reporting across companies. Some regulated processes may sit in specialist validated systems. The ERP must have clear boundaries with those systems.
The platform decision is therefore not only about features. It includes architecture, implementation method, partner capability, customization discipline, data ownership, security, upgrade approach and the organization’s ability to enforce standard ways of working.
What the Sasmar Story Makes Leaders Ask
Sasmar’s experience raises six strategic questions.
First, can a chosen platform evolve with the business over a decade instead of becoming a frozen legacy system? Second, can global growth happen without letting every legal entity create a separate process and data model? Third, how are eCommerce and marketplace operations connected to inventory and finance without losing control?
Fourth, when does customization solve a real pharmaceutical or commercial requirement and when does it create upgrade debt? Fifth, can regional teams work quickly while financial, master-data and access controls remain consistent? Finally, does the organization have the governance to operate the ERP as a long-term product rather than a one-time implementation?
The session’s focus on a growth path from six to 22 companies illustrates the scale of these questions. Company count alone does not prove global readiness. The important evidence is whether shared data, intercompany rules, reporting and change governance remained manageable as scope expanded.
Odoo and SAP: Compare the Decision Criteria, Not Slogans
Odoo and SAP can both support large organizations but they differ in product architecture, ecosystem, deployment choices, implementation patterns and commercial models. A responsible comparison should test each platform against the company’s own required outcomes and constraints.
| Decision criterion | Questions for Odoo evaluation | Questions for SAP evaluation |
|---|---|---|
| Process fit | Which needs are standard, configurable, integration-based or custom? | Which needs fit the selected SAP products and localization approach? |
| Global template | Can a governed template serve companies and regions without harmful workarounds? | Can the template be adopted at a pace and cost the organization can sustain? |
| Change speed | How quickly can approved process improvements be delivered and tested? | How will governance balance enterprise control with local change needs? |
| Integration | Which systems retain authority and how are failures reconciled? | Which interfaces, middleware and skills are required for the target landscape? |
| Total lifecycle cost | What will implementation, support, upgrades and extensions cost? | What will licences, implementation, operations and change cost? |
| Partner model | Does the team combine functional, technical and governance capability? | Does the partner have the correct product, industry and global delivery depth? |
The table is not a feature scorecard. The same answer can lead different groups to different conclusions. A company with heavily standardized operations, a mature enterprise architecture and large transformation capacity may value a different operating model from a group that needs modular rollout and close control of implementation scope.
Start With the Pharma Process Boundary
For an Odoo pharma ERP evaluation, map the process before selecting modules or estimating licences. A useful boundary may start with demand planning and purchasing then continue through receipt, quality release, production, warehousing, sales, invoicing and financial close.
The map should show the actual transaction. A purchase order creates expected inbound stock. Receipt creates traceable inventory status. Quality or release decisions determine whether stock can move into a usable state under the organization’s defined controls. Manufacturing consumes approved components and produces finished goods with documented traceability. Sales commitments draw from valid available stock. Delivery, invoicing, payment and accounting close the commercial flow.
Identify where specialist systems are mandatory or strategically preferred. Regulatory validation, laboratory systems, pharmacovigilance and clinical processes may demand specialized controls. The ERP must exchange data responsibly with those systems rather than claim to replace every application.
A Global Template Must Be Specific
“One global template” can be an empty slogan. Define which business rules must be shared and which local variations are legitimate.
Shared elements often include product identity, units of measure, chart-of-accounts principles, intercompany rules, approved roles, core approval policies, reporting definitions and master-data governance. Local variations may include tax rules, language, statutory reporting, approved local payment methods and country-specific commercial documents.
The goal is neither maximum centralization nor unlimited local freedom. It is a clear decision record for every variation. If a local company requires a different process, name the legal, customer, operational or risk reason. If no reason exists, the global rule should normally prevail.
| Area | Global standard to consider | Local variation to test |
|---|---|---|
| Product data | Product codes, specifications, units and lifecycle ownership | Local labels, language and permitted-market details |
| Finance | Accounting principles, intercompany policy and close controls | Tax, statutory reports and banking formats |
| Inventory | Locations, traceability rules and movement approval principles | Warehouse layout and local logistics partners |
| Commercial operations | Customer hierarchy, pricing governance and credit rules | Local market price lists and document requirements |
| Security | Role design, segregation and access-review method | Country-specific legal access constraints |
| Reporting | Core KPIs, definitions and data-quality standards | Local management views within governed definitions |
Customization: The Critical Long-Term Question
Ten-year ERP programs rarely remain entirely standard. New channels, acquisitions, regulations and operating practices create valid demands for change. The question is whether the organization makes those decisions through controlled architecture.
For each extension, test five points. Is the underlying business outcome material? Can configuration, process change or integration meet it? Who owns the requirement? How will it be tested and upgraded? What data and security effect does it create?
In a global pharmaceutical ERP, custom code should not become the hidden location for policy decisions. Approval rules, product status logic and access boundaries need documented business owners. Otherwise every upgrade becomes a forensic exercise to discover why code exists.
Sasmar’s long path from Odoo 7 to Odoo 19 is a useful reminder that upgradeability has to be designed. A system can grow in functionality while still requiring deliberate version planning, regression testing and a reviewed custom-module portfolio.
Multi-Company Architecture and Intercompany Control
Moving from six to 22 companies changes the ERP problem. A company record is not merely another reporting filter. It can affect users, access rights, currencies, tax positions, stock ownership, journals, intercompany transactions, price policies and local reporting.
Define which data is shared and which is company-specific. Product definitions might be governed globally while inventory quantities, customer credit exposure and accounting entries need company context. Group reporting needs clear mappings and reconciliation processes.
Intercompany flows need end-to-end tests. When one entity sells or transfers to another, the corresponding purchasing, logistics and accounting effects must follow the approved policy. Exceptions such as partial delivery, transfer pricing changes, return and currency differences require named owners and visible reconciliation.
Commerce and Marketplace Growth Need an ERP Control Plane
Sasmar’s story includes more than 25 Shopify stores plus Amazon operations. This raises a familiar global commerce question: how can many storefronts move quickly while product, stock, price, order and finance data remains controlled?
An effective design establishes authority by data object. For example, Odoo may govern product, stock and fulfilment availability while the storefront owns its presentation. Orders need stable identifiers, clear status mapping, retry rules, duplicate protection and reconciliation between commerce transactions, payment settlements and accounting records.
Do not evaluate an integration only by whether it sends orders. Test a full lifecycle: order created, stock reserved, shipment confirmed, cancellation or refund processed, settlement received and financial difference reconciled. Monitor the exceptions because they determine whether a fast-growing channel remains trustworthy.
Data Governance Is the Shared Foundation
Many ERP problems blamed on software are data problems. A global group needs named owners for product data, suppliers, customers, price conditions, bills of materials, financial mappings and company attributes. Each owner needs a definition of quality, change authority and review cycle.
For pharmaceutical operations, data governance must also account for product status, packaging, units, controlled specifications and local market constraints. Do not start a multi-company rollout with inconsistent product codes or ambiguous conversion rules. Clean data is not a one-time migration task. It is an operating discipline.
| Decision domain | Evidence leaders should require | Control signal |
|---|---|---|
| Product master | Owner, definitions, approval path and duplicate rules | Completeness and duplicate trend |
| Customization | Business case, test plan, upgrade owner and retirement review | Approved change register |
| Intercompany | Policy, transaction map and reconciliation method | Open differences and aging |
| Integrations | Data authority, error flow, monitoring and replay procedure | Failure rate and exception age |
| Access | Role matrix, review process and segregation evidence | Access-review completion |
| Rollout | Readiness criteria, cutover plan and hypercare ownership | Exit-gate approval |
A Practical Decision Framework
Use four gates before committing to either Odoo or SAP.
Gate 1: Business fit. Identify the critical processes, risk requirements, global expansion plans and measurable outcomes. Confirm executive sponsor and process owners.
Gate 2: Operating model fit. Define global standards, valid local variations, required specialist systems and architecture principles. Decide how customization and integration choices will be governed.
Gate 3: Evidence-based platform fit. Test real scenarios with representative data and exceptions. Score standard fit, configuration, integration work, change impacts and unresolved risks. Do not rely on generic demonstrations.
Gate 4: Delivery and lifecycle readiness. Review partner capability, phased roadmap, total lifecycle cost, security, data readiness, support and upgrade strategy. Proceed only when the organization can own its responsibilities.
This framework may select Odoo, SAP, a specialist landscape or further discovery. The quality of the decision lies in the evidence and governance rather than the familiarity of the brand.
Executive Action List
Start by naming the global process owners and selecting one high-value transaction flow. Map it end to end with real data, controls and exceptions. Record which applications own each business object and which systems are legally or operationally required to remain separate.
Next, create a global-template decision log. Mark rules as standard, locally variable or unresolved. Establish a customization council and master-data owners before implementation work begins. These decisions are architecture, not project administration.
Then run scenario-based evaluations against both options. Include multi-company access, intercompany flow, product traceability, commerce integration, financial close and exception handling. Score not only feature fit but also implementation effort, support model, upgrade impact and business adoption risk.
Finally, approve a phased roadmap. Start with a controlled scope that proves the operating model then expand only after data quality, controls, integration monitoring and user adoption meet agreed exit criteria.
Frequently Asked Questions
1. Did Sasmar migrate from SAP to Odoo?
No. Sasmar evaluated SAP but chose Odoo. The story is about a long Odoo transformation rather than an SAP-to-Odoo migration.
2. Can Odoo support a global pharmaceutical ERP environment?
It can support many global operational and financial processes but suitability depends on required controls, localizations, integrations and any specialist regulated systems. Evaluate real scenarios and governance rather than relying on general claims.
3. What should pharmaceutical groups test first?
Test one end-to-end flow involving product data, inventory status, manufacturing or procurement, sales, finance and a meaningful exception. Include multi-company context where it is material.
4. Is a global ERP template the same as identical processes everywhere?
No. A global template defines shared rules and data while allowing justified local variations such as tax, language, statutory reporting and legally required documents.
5. How should companies manage Odoo customizations over many years?
Maintain a register with the business owner, reason, code scope, test scenarios, upgrade impact and retirement decision. Review custom modules before each major upgrade.
6. Can Shopify and Amazon operations be controlled through Odoo?
They can be integrated but each business must define data authority, status mapping, error handling, duplicate protection and reconciliation. Test the complete order-to-settlement lifecycle.
7. What is the most important selection criterion: cost, features or scalability?
None should stand alone. Choose the operating model that fits the critical processes, controls, growth plan, delivery capacity and lifecycle governance. Total cost includes implementation, change and support over time.
Conclusion
The Sasmar Odoo story is most useful as a set of questions rather than a simple platform verdict. A 10-year transformation tests whether an ERP can evolve through more companies, commerce channels, data demands and governance pressures without losing control.
When choosing Odoo over SAP, pharmaceutical leaders should define the business operating model first. Compare global template fit, specialist-system boundaries, multi-company architecture, customization discipline, data governance, integration control and lifecycle cost using real scenarios.
The strongest choice is the one the organization can govern for the next decade. That requires more than a capable platform. It requires accountable owners, disciplined design decisions and a phased roadmap that turns global ambition into measurable operational control.
